{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:46:27Z","timestamp":1791773187279,"version":"4.3.4"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>Literature regarding outcomes associated with atrial fibrillation among cirrhosis patients who had left atrial appendage occlusion (LAAO) device procedure is limited. We aim to evaluate the in-hospital clinical outcomes and 30-day readmissions among LAAO with and without cirrhosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>We performed a retrospective study of all hospitalizations associated with the LAAO procedure, using the Nationwide Readmissions Database for the years 2016\u201319. Primary outcomes were in-hospital clinical outcomes and 30-day readmissions. A total of 54 897 index hospitalizations for LAAO (female 41.8%) were reported. Of these, 905(1.65%) had cirrhosis. Gastrointestinal (GI) bleeding was reported in 44 (4.9%) vs. 1606 (2.97%) and coagulopathy in 21 (2.3%) vs. 521 (0.96%) in cirrhosis and without-cirrhosis groups, respectively. A total of 872 (1.59%) patients needed blood transfusion, 24 (2.7%) vs. 848(1.57%) in cirrhosis vs. without-cirrhosis groups (P = 0.047). Fresh frozen plasma (FFP) transfusion was reported among 888 (1.62%), with cirrhosis 26 (3%) vs. without cirrhosis 862 (1.6%) (P = 0.05). On adjusted multivariate logistic regression analysis, acute kidney injury, coagulopathy, FFP transfusion, and blood transfusion were strongly associated with cirrhosis, and GI bleeding, ischaemic stroke, and intracranial haemorrhage were not associated with cirrhosis. Readmissions in 30 days were 5028 (9.18%), 167 (18.5%) in the cirrhosis group and 4861 (9%) without-cirrhosis group (P = 0.01). On multivariate Cox regression, CHA2DS2-Vasc score of six was significantly associated with 30-day readmission compared with other scores [hazard ratio 2.24; 95% confidence interval (1.58\u20133.16); P &amp;lt; 0.001].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Left atrial appendage occlusion procedure in patients with cirrhosis had relatively similar GI bleeding and stroke rates, however, had higher rates of 30-day readmission. A higher CHA2DS2-Vasc score was more likely to be associated with 30-day readmissions and hence would help in discharge planning. The long-term safety and efficacy of LAAO in the cirrhosis population need to be demonstrated.<\/jats:p><\/jats:sec>","DOI":"10.1093\/europace\/euad004","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T20:02:50Z","timestamp":1677700970000},"page":"1408-1414","source":"Crossref","is-referenced-by-count":14,"title":["Left atrial appendage closure device outcomes among cirrhosis patients with atrial fibrillation: a United States National Cohort Study"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6822-9600","authenticated-orcid":false,"given":"Tanveer","family":"Mir","sequence":"first","affiliation":[{"name":"Internal Medicine, Wayne State University, St Antoine street , Detroit, MI 48201 , USA"},{"name":"Internal Medicine, Baptist Health System, 400 Taylor Road Montgomery , AL 36117 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8601-0995","authenticated-orcid":false,"given":"Wasiq F","family":"Rawasia","sequence":"additional","affiliation":[{"name":"Clinical & Translational Science Institute, West Virginia University , Morgantown, WV 26506 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5206-0596","authenticated-orcid":false,"given":"Mohammed","family":"Uddin","sequence":"additional","affiliation":[{"name":"Internal Medicine, Wayne State University, St Antoine street , Detroit, MI 48201 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujeeb","family":"Sheikh","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Promedica Toledo Hospital , 2142 N Cove Blvd, Toledo, OH 43699 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9804-898X","authenticated-orcid":false,"given":"Muhammad Bilal","family":"Munir","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of California-Davis , 3941 J St, Sacramento, CA 95819 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7872-3757","authenticated-orcid":false,"given":"Sudarshan","family":"Balla","sequence":"additional","affiliation":[{"name":"Division of Cardiology, West Virginia University . Morgantown, WV 26506 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"2023041606545869400_","first-page":"257","article-title":"Atrial fibrillation: the most common arrhythmia","volume":"27","author":"Wyndham","year":"2000","journal-title":"Tex Heart Inst J"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: the Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0735-1097(19)31003-4","article-title":"Atrial fibrillation and liver cirrhosis: risks and benefits of anticoagulation","volume":"73","author":"Itani","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cld.1048","article-title":"Anticoagulation management in patients with atrial fibrillation and cirrhosis","volume":"17","author":"Shenoy","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/europace\/eux313","article-title":"Percutaneous left atrial appendage occlusion in atrial fibrillation patients with a contraindication to oral anticoagulation: a focused review","volume":"20","author":"Nishimura","year":"2018","journal-title":"Europace"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"2023041606545869400_"},{"key":"2023041606545869400_","author":"Agency for Healthcare Research and Quality"},{"key":"2023041606545869400_","first-page":"205","article-title":"[Liver cirrhosis and coagulopathy]","volume":"25","author":"Scharrer","year":"2005","journal-title":"Hamostaseologie"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.amjcard.2004.06.038","article-title":"Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study)","volume":"94","author":"Sam","year":"2004","journal-title":"Am J Cardiol"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/ajg.2009.164","article-title":"Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice","volume":"104","author":"Lanas","year":"2009","journal-title":"J Am Coll Gastroenterol"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","DOI":"10.1177\/1756284821997352","article-title":"Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients","volume":"14","author":"Deitelzweig","year":"2021","journal-title":"Ther Adv Gastroenterol"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.amjcard.2021.01.020","article-title":"Frequency, trend, predictors, and impact of gastrointestinal bleeding in atrial fibrillation hospitalizations","volume":"146","author":"Dave","year":"2021","journal-title":"Am J Cardiol"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/joic.12502","article-title":"An updated systematic review and meta-analysis of early outcomes after left atrial appendage occlusion","volume":"31","author":"Yerasi","year":"2018","journal-title":"J Interv Cardiol"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/europace\/euaa219","article-title":"Utilization and procedural adverse outcomes associated with Watchman device implantation","volume":"23","author":"Khalil","year":"2021","journal-title":"Europace"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1067\/mhj.2000.107177","article-title":"Heart diseases affecting the liver and liver diseases affecting the heart","volume":"140","author":"Naschitz","year":"2000","journal-title":"Am Heart J"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"195","DOI":"10.14218\/JCTH.2015.00015","article-title":"Acute kidney injury in patients with cirrhosis","volume":"3","author":"Russ","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"2023041606545869400_","article-title":"Thirty-day readmissions after percutaneous left atrial appendage occlusion: insights from the Nationwide Readmissions Database","author":"Sundhu","journal-title":"Curr Probl Cardiol"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/hep4.1472","article-title":"Thirty-day readmission and cost analysis in patients with cirrhosis: a nationwide population-based data","volume":"4","author":"Chirapongsathorn","year":"2020","journal-title":"Hepatol Commun"},{"key":"2023041606545869400_","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2017.06.090","article-title":"Atrial fibrillation: utility of CHADS(2) and CHA(2)DS(2)-VASc scores as predictors of readmission, mortality and resource utilization","volume":"245","author":"Lahewala","year":"2017","journal-title":"Int J Cardiol"},{"key":"2023041606545869400_","article-title":"Incidence and predictors of early death in patients undergoing percutaneous left atrial appendage closure","author":"Mesnier","journal-title":"JACC Clin Electrophysiol"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/4\/1408\/49919700\/euad004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/4\/1408\/49919700\/euad004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T17:39:23Z","timestamp":1701970763000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/25\/4\/1408\/7066664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,3,1]]},"published-print":{"date-parts":[[2023,4,15]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euad004","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,28]]},"published":{"date-parts":[[2023,3,1]]}}}